Unit costs of inpatient hospital days

PharmacoEconomics

Volumn 21, Issue 4, 2003, Pages 263-271

  Oostenbrink, Jan B ^a   Buijs Van Der Woude, Tineke ^b   Van Agthoven, Michel ^a   Koopmanschap, Marc A ^a   Rutten, Frans F H ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CALCULATION; COST BENEFIT ANALYSIS; ECONOMIC ASPECT; FINANCIAL MANAGEMENT; HEALTH CARE COST; HOSPITAL COST; HOSPITAL PATIENT; HOSPITALIZATION; INTENSIVE CARE UNIT; LENGTH OF STAY; NETHERLANDS; NURSE; PRIORITY JOURNAL; SALARY; WARD;

DATA COLLECTION; DIRECT SERVICE COSTS; HOSPITAL COSTS; HOSPITAL UNITS; HUMANS; INPATIENTS; INTENSIVE CARE; LENGTH OF STAY; NETHERLANDS;

EID: 0344837709     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200321040-00004     Document Type: Article

References (18)

1. Drummond MF, O'Brien B, Stoddart GL, et al. Methods for the economic evaluation of health care programmes. 2nd ed. New York: Oxford University Press, 1997
2. Gold MR, Siegel JE, Russell LB, et al. Cost-effectiveness in health and medicine. 1st ed. New York: Oxford University Press, 1996
3. Goeree R, Gafni A, Hannah M, et al. Hospital selection for unit cost estimates in multicentre economic evaluations; does the choice of hospitals make a difference. Pharmacoeconomics 1999; 15 (6): 561-72
4. Raikou M, Briggs A, Gray A, et al. Centre-specific or average unit costs in multi-centre studies?: some theory and simulation. Health Econ 2000; 9: 191-8
5. Hakkaart-van Roijen L. Societal perspective on the cost of illness [PhD thesis]. Rotterdam: Erasmus Medical Center, 1998
6. Polder JJ. Cost of illness in the Netherlands [PhD thesis]. Rotterdam: Erasmus Medical Center, 2001
7. Sullivan SD, Ramsey SD, Lee TA. The economic burden of COPD. Chest 2000; 117: 5S-9S
8. van Agthoven M, Vellenga E, Fibbe WE, et al. Cost analysis and quality of life assessment comparing patients undergoing autologous peripheral blood stem cell transplantation or autologous bone marrow transplantation for refractory or relapsed non-Hodgkin's lymphoma or Hodgkin's disease: a prospective randomised trial. Eur J Cancer 2001; 37 (14): 1781-9
9. Oostenbrink JB, Koopmanschap MA, Rutten FFH. Manual for costing: methods and standard costs for economic evaluations in healthcare [in Dutch]. Amstelveen: College voor zorgverzekeringen, 2000
10. Oostenbrink JB, Koopmanschap MA, Rutten FFH. Standardisation of costs; the Dutch manual for costing in economic evaluations. PharmacoEconomics 2002; 20 (7): 443-54
11. Riteco JA, Heij LJM de, Luijn JCF van, et al. Dutch guidelines for pharmacoeconomic research. Amstelveen: Health Insurance Council, 1999 Mar
12. Dutch Hospital Institute. NZI rekeningenschema voor Gezondheidszorginstellingen en verzorgingshuizen. (NZI cost accounting scheme for intramural organisations in healthcare). Utrecht: Dutch Hospital Institute. 1994
13. Horngren CT. Cost accounting. 5th ed. Englewood Cliffs: Prentice-Hall, 1982
14. Davidoff AJ, Powe NR. The role of perspective in defining economic measures for the evaluation of medical technology. Int J Technol Assess 1996; 12-1: 9-21
15. Commonwealth Department of Health and Ageing. Manual of resource items and their associated costs. Canberra 2002. Available from URL: http://www.health.gov.au/pbs/pubs/manual [Accessed 2003 Jan 28]
16. Jacobs P, Roos NP. Standard cost lists for healthcare in Canada. Pharmacoeconomics 1999; 15 (6): 551-60
17. Institute of Health Economics. A national list of provincial costs for health care 1997/8. Edmonton: Institute of Health Economics, 2000
18. Ferguson B. NHS database of reference costs is severely flawed. BMJ 2001; 323: 106